QuickMind VR Clinical Evidence

This review pooled 11 randomized trials involving 525 participants with mild cognitive impairment. It reported improvements in global cognition, attention and executive function, while memory effects were not statistically significant.

Evidence scope: Independent research across different VR interventions, not a trial of QuickMind VR. Differences in study quality, interventions and populations limit generalization to a marketed device.

DOI: 10.3389/fnhum.2024.1467697

The VECA study evaluated eye tracking, VR and machine learning in 201 participants in Shenzhen. The model predicted MoCA scores and classified cognitive impairment across educational groups.

Evidence scope: Single-location study; performance is specific to the studied population and model. Correlation is not diagnostic accuracy. International validation and marketed-version equivalence require confirmation.

npj Digital Medicine. 2024;7:219.

DOI: 10.1038/s41746-024-01206-5

A study of 77 early-AD patients and 58 cognitively unimpaired participants combined Dr.Brain™ hippocampal measurements with VR eye-tracking assessment. The combined model had an AUC of 0.825, compared with 0.629 for hippocampal volume alone.

Evidence scope: Single-center, cross-sectional study with education imbalance. The combined model result is not a standalone product claim or proof of population-wide diagnostic performance.

Chinese Journal of Magnetic Resonance Imaging. 2024;15(6):49–53.

DOI: 10.12015/issn.1674-8034.2024.06.007

Among 823 adults aged 65 or older in Shenzhen, machine-learning models combined AD8 responses with health characteristics to screen for cognitive impairment. The multilayer perceptron achieved an AUC of 0.83 ± 0.04, compared with 0.65 for the AD8 reference approach.

Evidence scope: Community data with cross-validation, without independent international validation. This AD8-based model does not directly establish VR hardware performance, rehabilitation efficacy or full-pathway dementia outcomes.

BMC Public Health. 2024;24:1206.

DOI: 10.1186/s12889-024-18692-7